Home1541 • HKG
add
ImmuneOnco Biopharmaceuticls Shanghi Inc
Previous close
$4.34
Day range
$4.41 - $4.64
Year range
$3.43 - $16.80
Market cap
1.92B HKD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 55.14M | 39.92% |
Operating expense | 90.46M | -24.10% |
Net income | -33.00M | 56.03% |
Net profit margin | -59.84 | 68.58% |
Earnings per share | — | — |
EBITDA | -33.30M | 57.04% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.02B | 35.09% |
Total assets | 1.10B | 19.13% |
Total liabilities | 308.27M | 26.50% |
Total equity | 790.13M | — |
Shares outstanding | 417.52M | — |
Price to book | 2.28 | — |
Return on assets | -8.16% | — |
Return on capital | -8.81% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -33.00M | 56.03% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2015
Website
Employees
202
